STOCKHOLDERS' EQUITY (Tables)

6 Months Ended

Dec. 31, 2021

Equity [Abstract]

Schedule of option activity

	Options		Weighted- Average Exercise Price		Weighted- Average Remaining Contractual Life		Aggregate Intrinsic Value
Outstanding at July 1, 2021		10,471,600	$	0.77		3.7	$	6,064,335
Granted		—		—
Exercised		—		—
Forfeited		—		—
Expired		—		—
Outstanding at December 31, 2021		10,471,600	$	0.77		3.2	$	9,624,679
Exercisable at December 31, 2021		10,471,600	$	0.77		3.2	$	9,624,679

Schedule of non vested stock options

	Options		Weighted Average Grant-Date Fair Value
Nonvested at July 1, 2021		—	$	—
Granted		—		—
Vested		—		—
Nonvested at December 31, 2021		—	$	—

Condensed Financial Statement

	Three months ended December 31, 2021		Three months ended December 31, 2020		Six months ended December 31, 2021		Six months ended December 31, 2020
General and administrative:
Change in fair value from modification of     option terms	$	—	$	8,775	$	—	$	8,775
Change in fair value from modification of     warrant terms		5,625		25,506		5,625		25,506
Fair value of stock options expensed		—		—		—		—
Total	$	5,625	$	34,281	$	5,625	$	34,281
Research and development:
Fair value of stock options expensed	$	—	$	—	$	—	$	—
Total	$	—	$	—	$	—	$	—